ÂÜÀòÂÒÂ×

Houman Ashrafian is an accomplished professional in the field of medicine and research, currently serving as the Executive Vice President and Head of Research and Development at Sanofi. Ashrafian holds the position of Chairman of the Board at Weatherden and Mestag Therapeutics and is the Head of Experimental Therapeutics at the University of Oxford's Radcliffe Department of Medicine. Additionally, Ashrafian contributes as an Honorary Consultant Cardiologist and co-leads the inherited cardiac conditions service at Oxford University Hospitals NHS Foundation Trust. Academic qualifications include a Doctor of Philosophy (Ph.D.) in Cardiovascular Medicine and a BM BCh in Medicine, both from the University of Oxford.